EFFECTS OF ADRIAMYCIN AND CYCLOPHOSPHAMIDE TREATMENT ON INDUCTION OF MACROPHAGE CYTOTOXIC FUNCTION IN MICE
- 1 January 1979
- journal article
- research article
- Vol. 39 (8) , 3014-3017
Abstract
The effects of i.p. and s.c. adriamycin and cyclophosphamide treatment of BALB/c .times. DBA/2 F1 mice were studied alone and in combination with immunotherapeutic agents, pyran copolymer and BCG, on macrophage cytotoxic ability. As assessed by direct viable cell counts of MBL-2 leukemia cells, adriamycin and cyclophosphamide produced growth-inhibitory macrophages. This function after s.c. cytostatic treatment peaked at day 1 and decreased progressively, attaining normal control values by day 6. When adjuvants, such as pyran and BCG, were administered i.p. simultaneously with s.c. adriamycin or cyclophosphamide, adjuvant-induced cytotoxic function was not markedly affected. A better knowledge of the influence was not markedly affected. A better knowledge of the influence of cytostatic agents alone or combined with immunoadjuvants on macrophage cytotoxic ability may be useful in designing more effective chemoimmunotherapy protocols.This publication has 16 references indexed in Scilit:
- Interferon: An Inducer of Macrophage Activation by PolyanionsScience, 1977
- Macrophage Function in Tumor-Bearing Mice: Tumoricidal and Chemotactic Responses of Macrophages Activated by Infection with Mycobacterium Bovis, Strain BCGThe Journal of Immunology, 1977
- Direct activation in vitro of mouse peritoneal macrophages by pyran copolymer (NSC 46015)Cellular Immunology, 1977
- Effects of variation in time and dose of cyclophosphamide injection on delayed hypersensitivity and antibody formationCellular Immunology, 1977
- INVITRO AND INVIVO CYTOTOXICITY OF ADRIAMYCIN AND DAUNOMYCIN FOR MURINE MACROPHAGES1977
- MACROPHAGE INVOLVEMENT IN PROTECTIVE EFFECT OF PYRAN COPOLYMER AGAINST MADISON LUNG CARCINOMA (M109)1977
- Augmentation of specific macrophage-mediated cytotoxicity: Correlation with agents which enhance antitumor resistanceCellular Immunology, 1976
- COMBINATION CHEMOTHERAPY WITH ADRIAMYCIN (NSC-123127) AND CYCLOPHOSPHAMIDE (NSC-26271) FOR SOLID TUMORS - PHASE-2 TRIAL1976
- CHARACTERIZATION OF IMMUNOSUPPRESSIVE ACTIVITY OF ADRIAMYCIN AND DAUNOMYCIN ON HUMORAL ANTIBODY-PRODUCTION AND TUMOR ALLOGRAFT-REJECTION1976
- AdriamycinAnnals of Internal Medicine, 1974